4Mercorelli B, Lembo D, Palu G. Early inhibitors of human cytomegalovirus : State-of- art and therapeutic perspectives [J]. Pharmacol Ther, 2011, 131 (3) : 309 -329. 被引量：1
5Maher KG, Rajiv K. Human cytomegalovirus: clinical aspects, immune reg- ulation, and emerging treatments [J]. Lancet Infect Dis, 2004, 12 (9) : 725 - 738. 被引量：1
8Slifkin M,Ruthazer R,Freeman R,et al.Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation[J].Liver Transpl,2005,11(12);1597-1602. 被引量：1
9Mamun-Al-Mahtab,Rahman S,Khan M.Acute cytomegalovirus hepatitis in immunocompetent host[J].Kathmandu Univ Med J(KUMJ),2009,7(25):79-81. 被引量：1
10Vancfkov6 Z,Kucerovd T,Pelikdn L,et al.Perinatal cytomegalovirus hepatitis:to treat or not to treat with ganciclovir[J].J Paediatr Child Health,2004,40(8):444-448. 被引量：1
